Premium
Combined therapy for thyroid squamous cell carcinoma
Author(s) -
De Vos Filip Yves F. L.,
Sewnaik Aniel,
de Wilt J. Hans W.,
Smid Ernst J.,
den Bakker Michael A.,
van Meerten Esther
Publication year - 2012
Publication title -
head and neck
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.012
H-Index - 127
eISSN - 1097-0347
pISSN - 1043-3074
DOI - 10.1002/hed.21484
Subject(s) - medicine , basal cell , thyroid , paclitaxel , induction chemotherapy , cisplatin , chemotherapy , oncology , head and neck , thyroid carcinoma , head and neck squamous cell carcinoma , surgery , radiology , radiation therapy , head and neck cancer
Background. Squamous carcinoma of the thyroid is a rare aggressive disease, resulting in poor prognosis. Methods and Results. We combined cisplatin with paclitaxel on a weekly basis as induction therapy, achieving a high cumulative dose, in a patient with squamous cell tumor of the thyroid with arterial encasement. After surgery, pathologic examination confirmed a complete resection of the primary tumor with clear margins, revealing a successful induction treatment with chemotherapy. Conclusions. Our patient now has a recurrence‐free survival of >20 months, longer than the mean survival described in the literature. © 2010 Wiley Periodicals, Inc. Head Neck, 2012
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom